NeOAdjuvant Herceptin (NOAH) trial: formalin-fixed, paraffin-embedded breast cancer biopsies
Analysis of FFPE core biopsies from pre-treated patients with HER2+ breast cancer (BC) randomized to receive neoadjuvant chemotherapy only or chemotherapy+trastuzumab (herceptin). Results provide insight into the molecular basis of survival outcomes following trastuzumab-based chemotherapy.
Cancer Type: Breast Cancer
GPL: 570
Number of Genes with Data: 940
Number Observations: 156
Number Outputs: 1
Imbalanced Ratio: 0.368421053
Default Task: Classification